Gara Jalqabaatti › Saree (Gosoota Hunda) › Illinois › Chicago
Qorannoo klinikaalii Saree (Gosoota Hunda) Chicago, IL keessatti
Qorannoo 51 Saree (Gosoota Hunda) f Chicago fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study to Evaluate Adverse Events, Change in Disease Activity, Tolerability, and How Intravenous ABBV-438 Moves Through the Body in Adult Participants With Multiple Myeloma (MM)
Namoota walitti qabaa jiraSadarkaa 1
- University of Chicago Medical Center /ID# 278863, Chicago
uTRACT Jelmyto Registry: A Registry of Patients With Upper Tract Urothelial Cancer (UTUC) Treated With Jelmyto
Namoota walitti qabaa jiraQorannoo ilaalaa
- Northwestern University, Chicago
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
Namoota walitti qabaa jiraSadarkaa 3
- Investigative Site, Chicago
A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
Namoota walitti qabaa jiraSadarkaa 3
- University of Illinois Chicago, Chicago
A Study of Zolbetuximab Together With Pembrolizumab and Chemotherapy in Adults With Gastric Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern Memorial Hospital, Chicago
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Chicago Medical Center /ID# 280149, Chicago
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Cancer Treatment Centers of America-Chicago, Chicago
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Namoota walitti qabaa jiraSadarkaa 2/3
- Northwestern Memorial Hospital, Chicago
- University Of Chicago Medical Center, Chicago
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
Namoota walitti qabaa jiraSadarkaa 2
- Rush University Medical Center, Chicago
- University of Chicago Medical Center, Chicago
Evaluating the Communication Between Patients and Providers in Cancer Clinics
Namoota walitti qabaa jira
- Northwestern Memorial Hospital, Chicago
The ECOG-ACRIN SUPPORT Trial: Multilevel Intervention to Improve Diverse Enrollment in Cancer Clinical Trials
Namoota walitti qabaa jira
- Advocate Illinois Masonic Medical Center, Chicago
A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001)
Namoota walitti qabaa jiraSadarkaa 1
- Northwestern University ( Site 0101), Chicago
A Phase 1/1b Study of IAM1363 in HER2 Cancers
Namoota walitti qabaa jiraSadarkaa 1
- University of Chicago, Chicago
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Namoota walitti qabaa jiraSadarkaa 3
- University of Illinois at Chicago, Chicago
- University of Chicago Hospital, Chicago
Ovarian Tissue Cryopreservation in Post Pubertal (OTC-Post Pubertal)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ann &Robert H Lurie Children's Hospital, Chicago
A Longitudinal Multi-Omic Biomarker Profiling Study of Patients With Head & Neck Squamous Cell Carcinoma (HNSCC)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Northwestern University Feinberg School of Medicine, Chicago
Study of Sotorasib, Panitumumab and FOLFIRI Versus FOLFIRI With or Without Bevacizumab-awwb in Treatment-naïve Participants With Metastatic Colorectal Cancer With KRAS p.G12C Mutation
Namoota walitti qabaa jiraSadarkaa 3
- Insight Research Institute, Chicago
Ovarian Tissue Cryopreservation in Pre-Pubertal (OTC-Pre Pubertal)
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ann & Robert H Lurie Childrens Hospital, Chicago
Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.
Namoota walitti qabaa jiraSadarkaa 3
- Northwestern University, Chicago
Project: Every Child for Younger Patients With Cancer
Namoota walitti qabaa jiraQorannoo ilaalaa
- Lurie Children's Hospital-Chicago, Chicago
- Northwestern University, Chicago
- University of Illinois, Chicago
- fi 1 dabalataa
Abatacept in Immune Checkpoint Inhibitor Myocarditis
Namoota walitti qabaa jiraSadarkaa 3
- University of Chicago, Chicago
Two Part Study of Nenocorilant Combined With Nivolumab in Patients With Advanced Solid Malignancies
Namoota walitti qabaa jiraSadarkaa 1/2
- Site 05, Chicago
A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago Medical Center, Chicago
Tempus Open Link for Individual Voices in Innovative Analytics Registry: Platform Protocol for Multimodal Real-World Evidence in Cancer
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Tempus AI, Chicago
International Rare Brain Tumor Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
Namoota walitti qabaa jiraSadarkaa 2
- Ann & Robert H Lurie Children's Hospital of Chicago, Chicago
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
Namoota walitti qabaa jiraSadarkaa 3
- John H Stroger Jr Hospital of Cook County, Chicago
- University of Illinois, Chicago
- University of Chicago Comprehensive Cancer Center, Chicago
- fi 1 dabalataa
Illuminate: A Clinical Study Evaluating CAR T Immune Cell Therapy (BCB-276) for Patients With Diffuse Intrinsic Pontine Glioma (DIPG).
Namoota walitti qabaa jiraSadarkaa 2
- Lurie Children's Hospital, Chicago
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- The University of Chicago Medicine, Chicago
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
Namoota walitti qabaa jiraSadarkaa 2
- University of Chicago Medical Center /ID# 274742, Chicago
Sun Exposure and Activities After Skin Cancer: Optimization of mHealth Interventions
Namoota walitti qabaa jira
- Northwestern University, Chicago
Mobile Health Intervention to Support Oral Chemotherapy Adherence in Adolescents and Young Adults With Leukemia
Namoota walitti qabaa jira
- Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago
Molecular Genetics Studies of Cancer Patients and Their Relatives
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- John H Stroger Jr Hospital of Cook County, Chicago
- Rush University Medical Center, Chicago
Advancing Cancer Control Engaged Research Through Transformative Solutions (ACCERT) Social Determinants of Health (SDoH) Navigation Program
Namoota walitti qabaa jiraHojjettoota fayyaa simatamoo
- Northwestern University, Chicago
Childhood Cancer Survivor Study
Namoota walitti qabaa jiraQorannoo ilaalaaHojjettoota fayyaa simatamoo
- Ana & Robert H. Lurie Children's Hospital of Chicago, Chicago
- University of Chicago, Chicago
Lactulose to Improve Gut Health in Cancer Patients Receiving Immunotherapy
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago Medicine Comprehensive Cancer Center, Chicago
CT-95 in Advanced Cancers Associated With Mesothelin Expression
Namoota walitti qabaa jiraSadarkaa 1
- Context Investigational Site, Chicago
A Study to Evaluate the Safety, Tolerability, and Efficacy of MORAb-202 (Herein Referred to as Farletuzumab Ecteribulin), a Folate Receptor Alpha (FRα)-Targeting Antibody-drug Conjugate (ADC) in Participants With Selected Tumor Types
Namoota walitti qabaa jiraSadarkaa 1/2
- Northwestern Memorial Hospital, Chicago
Post Mortem Tissue Donation of Pediatric Tumor Tissues and Cells
Namoota walitti qabaa jiraQorannoo ilaalaa
- Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago
My Wellbeing Guide: A Novel Tool for Managing Stress and Improving Quality of Life
Namoota walitti qabaa jira
- Northwestern University, Chicago
A Study of Repotrectinib (TPX-0005) in Patients With Advanced Solid Tumors Harboring ALK, ROS1, or NTRK1-3 Rearrangements
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago, Chicago
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago Medical Center, Chicago
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
Namoota walitti qabaa jiraSadarkaa 2
- University of Chicago, Chicago
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Namoota walitti qabaa jiraSadarkaa 1/2
- Northwestern Memorial Hospital, Chicago
Evaluating Personalized Therapeutics Clinic (PTC) on Drug-Drug Interactions and Drug-Gene Interactions
Namoota walitti qabaa jira
- University of Chicago Medicine, Chicago
Safety, PK, and Preliminary Efficacy of MBRC-101 in Advanced Refractory Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1/2
- University of Chicago Medical Center, Chicago
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Chicago
Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma.
Namoota walitti qabaa jiraSadarkaa 1
- Northwestern University, Chicago
- University of Illinois, Chicago
A Study of NX-1607 in Adults With Advanced Malignancies
Namoota walitti qabaa jiraSadarkaa 1
- University of Chicago, Chicago
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
Namoota walitti qabaa jira
- Advocate Illinois Masonic Medical Center, Chicago
DREAM: Double Lung Transplant REgistry Aimed for Lung-limited Malignancies
Namoota walitti qabaa jiraQorannoo ilaalaa
- Thoracic Surgery, Canning Thoracic Institute (Northwestern Memorial Hospital), Chicago
Qorannoo Saree (Gosoota Hunda) magaalota biroo keessatti
- Houston, TXQorannoo 121
- New York City, NYQorannoo 109
- Boston, MAQorannoo 85
- Los Angeles, CAQorannoo 74
- Nashville, TNQorannoo 65
- Philadelphia, PAQorannoo 59
- Washington, DCQorannoo 58
- Durham, NCQorannoo 58
- Atlanta, GAQorannoo 49
- Seattle, WAQorannoo 49
- Arlington, VAQorannoo 48
- St. Louis, MOQorannoo 46
Qorannoo biroo Chicago keessatti
- Kansara Qara'a Non-Small CellQorannoo 61
- Saree OljooQorannoo 59
- Kansara MetastatikiiQorannoo 45
- Kansarii ProstateQorannoo 45
- Dhibee QaraQorannoo 41
- ObesityQorannoo 41
- Kansarii OvariiQorannoo 36
- Kansarii ColorectalQorannoo 34
- StrokeQorannoo 34
- Cufama OnneeQorannoo 31
- Baayyee UlfaataaQorannoo 29
- Kansa Selii Skwaamoo Mataa fi MormaQorannoo 26
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.